Silence Therapeutics plc

8-K/A Director or officer change Jul 16, 2026 8-K Regulation FD disclosure Jun 23, 2026 8-K Shareholder vote results Jun 16, 2026 8-K Other events Jun 11, 2026 8-K Entered a material agreement; Terminated a material agreement; Other events May 18, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 10-K Fiscal year ended 2025-12-31 Mar 5, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 5, 2026 8-K/A Director or officer change Dec 22, 2025 8-K Director or officer change Dec 22, 2025 8-K Director or officer change; Regulation FD disclosure Dec 15, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Other events Oct 23, 2025 8-K Director or officer change Aug 14, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Shareholder vote results Jun 27, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Director or officer change; Regulation FD disclosure May 6, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 30, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Feb 27, 2025 8-K Regulation FD disclosure Jan 2, 2025 6-K Dec 9, 2024 6-K Nov 18, 2024 6-K Nov 14, 2024 6-K Aug 15, 2024 6-K Jun 27, 2024 6-K FORM 6-K Jun 24, 2024 6-K Jun 20, 2024 6-K May 17, 2024 6-K May 16, 2024 6-K May 1, 2024 6-K Apr 29, 2024 6-K Apr 15, 2024 20-F Mar 13, 2024 6-K Mar 13, 2024